A5014021558- Public Health Policies and Education
- Health Systems, Economic Evaluations, Quality of Life
- Primary Care and Health Outcomes
- Antibiotic Resistance in Bacteria
- Healthcare Policy and Management
- Health disparities and outcomes
- Antibiotic Use and Resistance
- Bacterial Identification and Susceptibility Testing
- Lipoproteins and Cardiovascular Health
- Global Health Workforce Issues
- Food Security and Health in Diverse Populations
- Obesity and Health Practices
- Nutritional Studies and Diet
- Employment and Welfare Studies
- Chronic Disease Management Strategies
- Diabetes and associated disorders
- Climate Change and Health Impacts
- Treatment of Major Depression
- Healthcare cost, quality, practices
- Global Health Care Issues
- Pharmaceutical industry and healthcare
- Pharmaceutical Practices and Patient Outcomes
- Research, Science, and Academia
- Global Public Health Policies and Epidemiology
- Vagus Nerve Stimulation Research
Community Catalyst
2024
University of California, Berkeley
2024
Unity Health System
2022
University of California, San Francisco
2022
New York City Health and Hospitals Corporation
2013-2016
NYU Langone Health
2015
New York University
2013-2015
Brigham and Women's Hospital
2012
Harvard University
2012
Society for Healthcare Epidemiology of America
2010
In January 2002, the US Food and Drug Administration (FDA) issued a draft guidance requiring more detailed financial conflict of interest disclosure at advisory committee meetings.To characterize disclosures drug-related meetings, to assess relationship between conflicts voting behavior meetings that considered specific products.Cross-sectional study using agendas transcripts from all FDA Advisory Committee (2001-2004) listed on Web site.Conflict rates, type, size. The having in favor index...
Carbapenem-resistant Klebsiella pneumoniae (CRKP) is resistant to almost all antimicrobial agents, and CRKP infections are associated with substantial morbidity mortality.To describe an outbreak of in Puerto Rico, determine risk factors for acquisition, detail the successful measures taken control outbreak.Two case-control studies.A 328-bed tertiary care teaching hospital.Twenty-six case patients identified during period February through September 2008, 26 randomly selected uninfected...
Government austerity is likely to hit public health programs hard, as these compete for funds against the care delivery juggernaut. But such an approach seems hamper efforts improve population and reduce medical spending.
Our website uses cookies to enhance your experience. By continuing use our site, or clicking "Continue," you are agreeing Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications Network Open Cardiology Dermatology Health Forum Internal Medicine Neurology Oncology Ophthalmology Otolaryngology–Head & Neck Surgery Pediatrics Psychiatry Archives of (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning /...
A survey of the NEJM Catalyst Insights Council finds that Covid-19 pandemic improved coordination across public health and care delivery sectors, but formal integration has not progressed since then.
Our website uses cookies to enhance your experience. By continuing use our site, or clicking "Continue," you are agreeing Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications Network Open Cardiology Dermatology Health Forum Internal Medicine Neurology Oncology Ophthalmology Otolaryngology–Head & Neck Surgery Pediatrics Psychiatry Archives of (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning /...
Our website uses cookies to enhance your experience. By continuing use our site, or clicking "Continue," you are agreeing Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications Network Open Cardiology Dermatology Health Forum Internal Medicine Neurology Oncology Ophthalmology Otolaryngology–Head & Neck Surgery Pediatrics Psychiatry Archives of (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning /...
Health system leaders sometimes adopt quality metrics without robust supporting evidence of improvements in and/or quantity life, which may impair rather than facilitate improved health outcomes. In brief, there is now no easy way to measure how much "health" conferred by a system. However, we argue that this goal achievable. Health-weighted composite have the potential synthesizing individual evidence-based into summary measure, utilizing relative weightings reflect amount benefit each...
This special theme issue of NEJM Catalyst Innovations in Care Delivery, guest edited by Nicholas Stine, MD, includes articles, case studies, and research reports on coordination across public health care delivery, Covid-19 response, tuberculosis screening, the 2022 mpox outbreak, pediatric asthma intervention, abortion reproductive care, data.
A common lament of the post–Affordable Care Act era is that clinical medicine and population health need to be more strongly integrated. Although there optimism new incentives will help achieve greater integration (Shortell, 2013), separation well entrenched, exceeding administrative disjunction between an individually-focused delivery system a […]
In Reply Dr Zelicoff points to several significant challenges for the development and implementation of successful riskbased quality measures, including limitations existing risk calculator tools ability clinicians interpret communicate statistical risk.We share sentiment that practical, standardized, validated approaches calculation communication are a research educational need.As effectively illustrates with example FRAX tool osteoporosis, best practice guidelines imperfectly applied on...
ChloraPrep 1 " was proven more effective for peripheral IVs A reo?"t s* dy -orpa'ea :MP f < h i irrt'p' :>epp* i2*& ciiorhewd.iegtjcorv»te,' 7 0 , fe sop r op>l alcoh«< *o 70°.kOQ'r 0)<"• nht 'if-A *> pr, or to pp'i^erdl venous a n j atior iP*'G • Tne s\idy ^ uw.t"ot ust g Ch. inPr^j pi \.,< per.Dhew IV iT-e'lton rra* help "-educe the risk lit * itseqiii-iv PI'L or'tam atirr i1 o l izdtiur o-noa'tid wrtr usrg 70% IPA aloner tip, m -ho ""0°n iP£ arc.jp tcnpafed w t o' y•"3 8% T 2°3 THG iPA v...
SummaryInjectable biologics used for the treatment of retinal disease offer a strong use case ACOs, payers, and policy makers as they seek to manage total costs by reducing costly practice variation avoidable Medicare Part B drug spending. Bevacizumab, which was originally approved U.S. FDA in 2004 systemic advanced colon cancer, has seen increased off-label utilization vascular endothelial growth factor (VEGF) inhibitor disease. Three anti-VEGF medications that are commonly each have...